Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.

Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML.

J Sex Med. 2011 Mar;8(3):872-84. doi: 10.1111/j.1743-6109.2010.02157.x. Epub 2010 Dec 22. Review.

PMID:
21176115
2.

Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.

Corona G, Tirabassi G, Santi D, Maseroli E, Gacci M, Dicuio M, Sforza A, Mannucci E, Maggi M.

Andrology. 2017 Jul;5(4):671-678. doi: 10.1111/andr.12353. Epub 2017 Apr 28. Review.

PMID:
28453908
3.

Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.

Liu L, Zhao S, Li F, Li E, Kang R, Luo L, Luo J, Wan S, Zhao Z.

J Sex Med. 2016 Sep;13(9):1297-1310. doi: 10.1016/j.jsxm.2016.07.006. Epub 2016 Jul 27. Review.

PMID:
27475241
5.

Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.

Fertig RM, Gamret AC, Darwin E, Gaudi S.

Dermatol Online J. 2017 Nov 11;23(11). pii: 13030/qt24k8q743. Review.

PMID:
29447628
6.

Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?

Arias-Santiago S, Camacho-Martínez FM.

Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006. Epub 2016 Jul 18. English, Spanish. No abstract available.

PMID:
27436801
7.

5α-Reductase inhibitors in androgenetic alopecia.

Yim E, Nole KL, Tosti A.

Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):493-8. doi: 10.1097/MED.0000000000000112. Review. Erratum in: Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):73.

PMID:
25268732
8.

Persistent sexual side effects of finasteride for male pattern hair loss.

Irwig MS, Kolukula S.

J Sex Med. 2011 Jun;8(6):1747-53. doi: 10.1111/j.1743-6109.2011.02255.x. Epub 2011 Mar 18.

PMID:
21418145
9.

5-alpha reductase inhibitors and erectile dysfunction: the connection.

Erdemir F, Harbin A, Hellstrom WJ.

J Sex Med. 2008 Dec;5(12):2917-24. doi: 10.1111/j.1743-6109.2008.01001.x. Review.

PMID:
19090946
10.

Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M.

Rev Endocr Metab Disord. 2015 Sep;16(3):177-98. doi: 10.1007/s11154-015-9319-y. Review.

PMID:
26296373
11.

Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.

Traish AM, Haider KS, Doros G, Haider A.

Horm Mol Biol Clin Investig. 2015 Sep;23(3):85-96. doi: 10.1515/hmbci-2015-0015.

PMID:
26053014
12.

[Finasteride adverse effects: An update].

Carreño-Orellana N, Moll-Manzur C, Carrasco-Zuber JE, Álvarez-Véliz S, Berroeta-Mauriziano D, Porras-Kusmanic N.

Rev Med Chil. 2016 Dec;144(12):1584-1590. doi: 10.4067/S0034-98872016001200010. Review. Spanish.

13.

Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.

Gur S, Kadowitz PJ, Hellstrom WJ.

Expert Opin Drug Saf. 2013 Jan;12(1):81-90. doi: 10.1517/14740338.2013.742885. Epub 2012 Nov 22. Review.

PMID:
23173718
14.

Persistent sexual side effects of finasteride: could they be permanent?

Irwig MS.

J Sex Med. 2012 Nov;9(11):2927-32. doi: 10.1111/j.1743-6109.2012.02846.x. Epub 2012 Jul 12.

PMID:
22789024
15.

Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.

Corona G, Rastrelli G, Maseroli E, Balercia G, Sforza A, Forti G, Mannucci E, Maggi M.

J Endocrinol Invest. 2012 Nov;35(10):915-20. doi: 10.3275/8510. Epub 2012 Jul 9.

PMID:
22777612
16.

Androgenetic alopecia; drug safety and therapeutic strategies.

Motofei IG, Rowland DL, Baconi DL, Tampa M, Sârbu MI, Păunică S, Constantin VD, Bălălău C, Păunică I, Georgescu SR.

Expert Opin Drug Saf. 2018 Apr;17(4):407-412. doi: 10.1080/14740338.2018.1430765. Epub 2018 Jan 24. Review.

PMID:
29363345
17.

Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.

Melcangi RC, Caruso D, Abbiati F, Giatti S, Calabrese D, Piazza F, Cavaletti G.

J Sex Med. 2013 Oct;10(10):2598-603. doi: 10.1111/jsm.12269. Epub 2013 Jul 24.

PMID:
23890183
18.

Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.

Glina S, Roehrborn CG, Esen A, Plekhanov A, Sorsaburu S, Henneges C, Büttner H, Viktrup L.

J Sex Med. 2015 Jan;12(1):129-38. doi: 10.1111/jsm.12714. Epub 2014 Oct 29.

PMID:
25353053
19.

The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Traish AM, Mulgaonkar A, Giordano N.

Korean J Urol. 2014 Jun;55(6):367-79. doi: 10.4111/kju.2014.55.6.367. Epub 2014 Jun 16. Review.

20.

Supplemental Content

Support Center